nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—PTGS2—muscle cancer	0.63	1	CbGaD
Nabumetone—PTGS2—Etoposide—muscle cancer	0.0916	0.334	CbGbCtD
Nabumetone—PTGS1—Etoposide—muscle cancer	0.0773	0.282	CbGbCtD
Nabumetone—CYP1A2—Dacarbazine—muscle cancer	0.0706	0.258	CbGbCtD
Nabumetone—CYP1A2—Etoposide—muscle cancer	0.0346	0.126	CbGbCtD
Nabumetone—Vasculitis—Methotrexate—muscle cancer	0.00047	0.00496	CcSEcCtD
Nabumetone—Alopecia—Dactinomycin—muscle cancer	0.00047	0.00496	CcSEcCtD
Nabumetone—Sweating increased—Etoposide—muscle cancer	0.000468	0.00494	CcSEcCtD
Nabumetone—Blood uric acid increased—Methotrexate—muscle cancer	0.000467	0.00493	CcSEcCtD
Nabumetone—Jaundice cholestatic—Doxorubicin—muscle cancer	0.000452	0.00477	CcSEcCtD
Nabumetone—Melaena—Methotrexate—muscle cancer	0.000448	0.00473	CcSEcCtD
Nabumetone—Rectal haemorrhage—Doxorubicin—muscle cancer	0.00044	0.00464	CcSEcCtD
Nabumetone—Glossitis—Doxorubicin—muscle cancer	0.000431	0.00455	CcSEcCtD
Nabumetone—Pneumonia—Etoposide—muscle cancer	0.000431	0.00455	CcSEcCtD
Nabumetone—Aplastic anaemia—Methotrexate—muscle cancer	0.000431	0.00455	CcSEcCtD
Nabumetone—Ill-defined disorder—Dactinomycin—muscle cancer	0.000429	0.00453	CcSEcCtD
Nabumetone—Hyperuricaemia—Doxorubicin—muscle cancer	0.000428	0.00452	CcSEcCtD
Nabumetone—Anaemia—Dactinomycin—muscle cancer	0.000428	0.00452	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.000425	0.00449	CcSEcCtD
Nabumetone—Acute coronary syndrome—Etoposide—muscle cancer	0.000422	0.00446	CcSEcCtD
Nabumetone—Renal failure—Etoposide—muscle cancer	0.000421	0.00445	CcSEcCtD
Nabumetone—Myocardial infarction—Etoposide—muscle cancer	0.00042	0.00443	CcSEcCtD
Nabumetone—Alopecia—Vincristine—muscle cancer	0.00042	0.00443	CcSEcCtD
Nabumetone—Stomatitis—Etoposide—muscle cancer	0.000418	0.00441	CcSEcCtD
Nabumetone—Jaundice—Etoposide—muscle cancer	0.000418	0.00441	CcSEcCtD
Nabumetone—Malaise—Dactinomycin—muscle cancer	0.000417	0.00441	CcSEcCtD
Nabumetone—Leukopenia—Dactinomycin—muscle cancer	0.000414	0.00437	CcSEcCtD
Nabumetone—Blood uric acid increased—Doxorubicin—muscle cancer	0.000404	0.00427	CcSEcCtD
Nabumetone—Agranulocytosis—Etoposide—muscle cancer	0.0004	0.00422	CcSEcCtD
Nabumetone—Eructation—Doxorubicin—muscle cancer	0.00039	0.00412	CcSEcCtD
Nabumetone—Discomfort—Dactinomycin—muscle cancer	0.000389	0.00411	CcSEcCtD
Nabumetone—Melaena—Doxorubicin—muscle cancer	0.000388	0.0041	CcSEcCtD
Nabumetone—Thrombophlebitis—Methotrexate—muscle cancer	0.000385	0.00406	CcSEcCtD
Nabumetone—Anaemia—Vincristine—muscle cancer	0.000382	0.00403	CcSEcCtD
Nabumetone—Agitation—Vincristine—muscle cancer	0.00038	0.00401	CcSEcCtD
Nabumetone—Photosensitivity—Methotrexate—muscle cancer	0.000379	0.00401	CcSEcCtD
Nabumetone—Oedema—Dactinomycin—muscle cancer	0.000378	0.00399	CcSEcCtD
Nabumetone—Aplastic anaemia—Doxorubicin—muscle cancer	0.000373	0.00394	CcSEcCtD
Nabumetone—Vertigo—Vincristine—muscle cancer	0.000371	0.00392	CcSEcCtD
Nabumetone—Hepatic failure—Methotrexate—muscle cancer	0.000371	0.00391	CcSEcCtD
Nabumetone—Leukopenia—Vincristine—muscle cancer	0.00037	0.00391	CcSEcCtD
Nabumetone—Thrombocytopenia—Dactinomycin—muscle cancer	0.00037	0.0039	CcSEcCtD
Nabumetone—Erythema multiforme—Etoposide—muscle cancer	0.000364	0.00384	CcSEcCtD
Nabumetone—Anorexia—Dactinomycin—muscle cancer	0.00036	0.0038	CcSEcCtD
Nabumetone—Hypertension—Vincristine—muscle cancer	0.000357	0.00377	CcSEcCtD
Nabumetone—Abnormal vision—Doxorubicin—muscle cancer	0.000346	0.00366	CcSEcCtD
Nabumetone—Chills—Etoposide—muscle cancer	0.000345	0.00364	CcSEcCtD
Nabumetone—Anaphylactoid reaction—Methotrexate—muscle cancer	0.000344	0.00363	CcSEcCtD
Nabumetone—Alopecia—Etoposide—muscle cancer	0.00034	0.00359	CcSEcCtD
Nabumetone—Anaphylactic shock—Vincristine—muscle cancer	0.000337	0.00356	CcSEcCtD
Nabumetone—Oedema—Vincristine—muscle cancer	0.000337	0.00356	CcSEcCtD
Nabumetone—Thrombophlebitis—Doxorubicin—muscle cancer	0.000333	0.00352	CcSEcCtD
Nabumetone—Thrombocytopenia—Vincristine—muscle cancer	0.00033	0.00349	CcSEcCtD
Nabumetone—Photosensitivity—Doxorubicin—muscle cancer	0.000328	0.00347	CcSEcCtD
Nabumetone—Decreased appetite—Dactinomycin—muscle cancer	0.000328	0.00347	CcSEcCtD
Nabumetone—Hyperhidrosis—Vincristine—muscle cancer	0.000326	0.00344	CcSEcCtD
Nabumetone—Fatigue—Dactinomycin—muscle cancer	0.000325	0.00344	CcSEcCtD
Nabumetone—Anorexia—Vincristine—muscle cancer	0.000322	0.0034	CcSEcCtD
Nabumetone—Hepatic failure—Doxorubicin—muscle cancer	0.000321	0.00339	CcSEcCtD
Nabumetone—Feeling abnormal—Dactinomycin—muscle cancer	0.000311	0.00329	CcSEcCtD
Nabumetone—Ill-defined disorder—Etoposide—muscle cancer	0.000311	0.00328	CcSEcCtD
Nabumetone—Anaemia—Etoposide—muscle cancer	0.000309	0.00327	CcSEcCtD
Nabumetone—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000309	0.00326	CcSEcCtD
Nabumetone—Liver function test abnormal—Methotrexate—muscle cancer	0.000307	0.00325	CcSEcCtD
Nabumetone—Increased appetite—Doxorubicin—muscle cancer	0.000307	0.00324	CcSEcCtD
Nabumetone—Insomnia—Vincristine—muscle cancer	0.000305	0.00322	CcSEcCtD
Nabumetone—Paraesthesia—Vincristine—muscle cancer	0.000303	0.0032	CcSEcCtD
Nabumetone—Malaise—Etoposide—muscle cancer	0.000302	0.00319	CcSEcCtD
Nabumetone—Dermatitis bullous—Doxorubicin—muscle cancer	0.000302	0.00319	CcSEcCtD
Nabumetone—Vertigo—Etoposide—muscle cancer	0.000301	0.00318	CcSEcCtD
Nabumetone—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.0003	0.00317	CcSEcCtD
Nabumetone—Leukopenia—Etoposide—muscle cancer	0.0003	0.00316	CcSEcCtD
Nabumetone—Abdominal pain—Dactinomycin—muscle cancer	0.000298	0.00315	CcSEcCtD
Nabumetone—Body temperature increased—Dactinomycin—muscle cancer	0.000298	0.00315	CcSEcCtD
Nabumetone—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000298	0.00315	CcSEcCtD
Nabumetone—Loss of consciousness—Etoposide—muscle cancer	0.000294	0.00311	CcSEcCtD
Nabumetone—Decreased appetite—Vincristine—muscle cancer	0.000293	0.0031	CcSEcCtD
Nabumetone—Cough—Etoposide—muscle cancer	0.000292	0.00309	CcSEcCtD
Nabumetone—Fatigue—Vincristine—muscle cancer	0.000291	0.00307	CcSEcCtD
Nabumetone—Hypertension—Etoposide—muscle cancer	0.000289	0.00305	CcSEcCtD
Nabumetone—Constipation—Vincristine—muscle cancer	0.000288	0.00305	CcSEcCtD
Nabumetone—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.000288	0.00305	CcSEcCtD
Nabumetone—Asthma—Methotrexate—muscle cancer	0.000288	0.00304	CcSEcCtD
Nabumetone—Pancreatitis—Methotrexate—muscle cancer	0.000282	0.00298	CcSEcCtD
Nabumetone—Discomfort—Etoposide—muscle cancer	0.000282	0.00297	CcSEcCtD
Nabumetone—Hypersensitivity—Dactinomycin—muscle cancer	0.000278	0.00294	CcSEcCtD
Nabumetone—Gastrointestinal pain—Vincristine—muscle cancer	0.000276	0.00291	CcSEcCtD
Nabumetone—Confusional state—Etoposide—muscle cancer	0.000276	0.00291	CcSEcCtD
Nabumetone—Anaphylactic shock—Etoposide—muscle cancer	0.000273	0.00289	CcSEcCtD
Nabumetone—Asthenia—Dactinomycin—muscle cancer	0.000271	0.00286	CcSEcCtD
Nabumetone—Dysuria—Methotrexate—muscle cancer	0.000269	0.00284	CcSEcCtD
Nabumetone—Thrombocytopenia—Etoposide—muscle cancer	0.000268	0.00283	CcSEcCtD
Nabumetone—Abdominal pain—Vincristine—muscle cancer	0.000267	0.00282	CcSEcCtD
Nabumetone—Body temperature increased—Vincristine—muscle cancer	0.000267	0.00282	CcSEcCtD
Nabumetone—Liver function test abnormal—Doxorubicin—muscle cancer	0.000266	0.00281	CcSEcCtD
Nabumetone—Erectile dysfunction—Methotrexate—muscle cancer	0.000265	0.0028	CcSEcCtD
Nabumetone—Hyperhidrosis—Etoposide—muscle cancer	0.000264	0.00279	CcSEcCtD
Nabumetone—Photosensitivity reaction—Methotrexate—muscle cancer	0.000263	0.00277	CcSEcCtD
Nabumetone—Hypokalaemia—Doxorubicin—muscle cancer	0.000262	0.00277	CcSEcCtD
Nabumetone—Anorexia—Etoposide—muscle cancer	0.00026	0.00275	CcSEcCtD
Nabumetone—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00026	0.00274	CcSEcCtD
Nabumetone—Diarrhoea—Dactinomycin—muscle cancer	0.000258	0.00273	CcSEcCtD
Nabumetone—Pneumonia—Methotrexate—muscle cancer	0.000258	0.00273	CcSEcCtD
Nabumetone—Depression—Methotrexate—muscle cancer	0.000256	0.0027	CcSEcCtD
Nabumetone—Gastritis—Doxorubicin—muscle cancer	0.000255	0.00269	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000254	0.00269	CcSEcCtD
Nabumetone—Renal failure—Methotrexate—muscle cancer	0.000252	0.00266	CcSEcCtD
Nabumetone—Stomatitis—Methotrexate—muscle cancer	0.00025	0.00264	CcSEcCtD
Nabumetone—Dysphagia—Doxorubicin—muscle cancer	0.000249	0.00263	CcSEcCtD
Nabumetone—Asthma—Doxorubicin—muscle cancer	0.000249	0.00263	CcSEcCtD
Nabumetone—Hypersensitivity—Vincristine—muscle cancer	0.000249	0.00262	CcSEcCtD
Nabumetone—Paraesthesia—Etoposide—muscle cancer	0.000245	0.00259	CcSEcCtD
Nabumetone—Haematuria—Methotrexate—muscle cancer	0.000245	0.00258	CcSEcCtD
Nabumetone—Pancreatitis—Doxorubicin—muscle cancer	0.000244	0.00258	CcSEcCtD
Nabumetone—Dyspnoea—Etoposide—muscle cancer	0.000244	0.00257	CcSEcCtD
Nabumetone—Somnolence—Etoposide—muscle cancer	0.000243	0.00257	CcSEcCtD
Nabumetone—Angina pectoris—Doxorubicin—muscle cancer	0.000243	0.00256	CcSEcCtD
Nabumetone—Asthenia—Vincristine—muscle cancer	0.000242	0.00256	CcSEcCtD
Nabumetone—Vomiting—Dactinomycin—muscle cancer	0.00024	0.00253	CcSEcCtD
Nabumetone—Agranulocytosis—Methotrexate—muscle cancer	0.000239	0.00253	CcSEcCtD
Nabumetone—Rash—Dactinomycin—muscle cancer	0.000238	0.00251	CcSEcCtD
Nabumetone—Decreased appetite—Etoposide—muscle cancer	0.000238	0.00251	CcSEcCtD
Nabumetone—Fatigue—Etoposide—muscle cancer	0.000236	0.00249	CcSEcCtD
Nabumetone—Constipation—Etoposide—muscle cancer	0.000234	0.00247	CcSEcCtD
Nabumetone—Dysuria—Doxorubicin—muscle cancer	0.000233	0.00246	CcSEcCtD
Nabumetone—Haemoglobin—Methotrexate—muscle cancer	0.000232	0.00245	CcSEcCtD
Nabumetone—Diarrhoea—Vincristine—muscle cancer	0.000231	0.00244	CcSEcCtD
Nabumetone—Haemorrhage—Methotrexate—muscle cancer	0.00023	0.00243	CcSEcCtD
Nabumetone—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000227	0.0024	CcSEcCtD
Nabumetone—Weight increased—Doxorubicin—muscle cancer	0.000227	0.0024	CcSEcCtD
Nabumetone—Weight decreased—Doxorubicin—muscle cancer	0.000225	0.00238	CcSEcCtD
Nabumetone—Feeling abnormal—Etoposide—muscle cancer	0.000225	0.00238	CcSEcCtD
Nabumetone—Hyperglycaemia—Doxorubicin—muscle cancer	0.000225	0.00237	CcSEcCtD
Nabumetone—Nausea—Dactinomycin—muscle cancer	0.000224	0.00237	CcSEcCtD
Nabumetone—Pneumonia—Doxorubicin—muscle cancer	0.000223	0.00236	CcSEcCtD
Nabumetone—Gastrointestinal pain—Etoposide—muscle cancer	0.000223	0.00236	CcSEcCtD
Nabumetone—Dizziness—Vincristine—muscle cancer	0.000223	0.00236	CcSEcCtD
Nabumetone—Visual impairment—Methotrexate—muscle cancer	0.000222	0.00234	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00022	0.00233	CcSEcCtD
Nabumetone—Renal failure—Doxorubicin—muscle cancer	0.000218	0.00231	CcSEcCtD
Nabumetone—Erythema multiforme—Methotrexate—muscle cancer	0.000218	0.0023	CcSEcCtD
Nabumetone—Urticaria—Etoposide—muscle cancer	0.000217	0.00229	CcSEcCtD
Nabumetone—Stomatitis—Doxorubicin—muscle cancer	0.000217	0.00229	CcSEcCtD
Nabumetone—Jaundice—Doxorubicin—muscle cancer	0.000217	0.00229	CcSEcCtD
Nabumetone—Abdominal pain—Etoposide—muscle cancer	0.000216	0.00228	CcSEcCtD
Nabumetone—Body temperature increased—Etoposide—muscle cancer	0.000216	0.00228	CcSEcCtD
Nabumetone—Tinnitus—Methotrexate—muscle cancer	0.000215	0.00227	CcSEcCtD
Nabumetone—Vomiting—Vincristine—muscle cancer	0.000214	0.00226	CcSEcCtD
Nabumetone—Rash—Vincristine—muscle cancer	0.000213	0.00225	CcSEcCtD
Nabumetone—Dermatitis—Vincristine—muscle cancer	0.000212	0.00224	CcSEcCtD
Nabumetone—Haematuria—Doxorubicin—muscle cancer	0.000212	0.00224	CcSEcCtD
Nabumetone—Headache—Vincristine—muscle cancer	0.000211	0.00223	CcSEcCtD
Nabumetone—Agranulocytosis—Doxorubicin—muscle cancer	0.000207	0.00219	CcSEcCtD
Nabumetone—Chills—Methotrexate—muscle cancer	0.000207	0.00218	CcSEcCtD
Nabumetone—Alopecia—Methotrexate—muscle cancer	0.000204	0.00215	CcSEcCtD
Nabumetone—Hypersensitivity—Etoposide—muscle cancer	0.000201	0.00213	CcSEcCtD
Nabumetone—Haemoglobin—Doxorubicin—muscle cancer	0.0002	0.00212	CcSEcCtD
Nabumetone—Nausea—Vincristine—muscle cancer	0.0002	0.00212	CcSEcCtD
Nabumetone—Haemorrhage—Doxorubicin—muscle cancer	0.000199	0.00211	CcSEcCtD
Nabumetone—Asthenia—Etoposide—muscle cancer	0.000196	0.00207	CcSEcCtD
Nabumetone—Pruritus—Etoposide—muscle cancer	0.000193	0.00204	CcSEcCtD
Nabumetone—Visual impairment—Doxorubicin—muscle cancer	0.000192	0.00203	CcSEcCtD
Nabumetone—Erythema multiforme—Doxorubicin—muscle cancer	0.000189	0.00199	CcSEcCtD
Nabumetone—Diarrhoea—Etoposide—muscle cancer	0.000187	0.00197	CcSEcCtD
Nabumetone—Ill-defined disorder—Methotrexate—muscle cancer	0.000186	0.00196	CcSEcCtD
Nabumetone—Tinnitus—Doxorubicin—muscle cancer	0.000186	0.00196	CcSEcCtD
Nabumetone—Anaemia—Methotrexate—muscle cancer	0.000185	0.00196	CcSEcCtD
Nabumetone—Malaise—Methotrexate—muscle cancer	0.000181	0.00191	CcSEcCtD
Nabumetone—Dizziness—Etoposide—muscle cancer	0.000181	0.00191	CcSEcCtD
Nabumetone—Vertigo—Methotrexate—muscle cancer	0.00018	0.0019	CcSEcCtD
Nabumetone—Leukopenia—Methotrexate—muscle cancer	0.00018	0.0019	CcSEcCtD
Nabumetone—Chills—Doxorubicin—muscle cancer	0.000179	0.00189	CcSEcCtD
Nabumetone—Arrhythmia—Doxorubicin—muscle cancer	0.000178	0.00188	CcSEcCtD
Nabumetone—Alopecia—Doxorubicin—muscle cancer	0.000176	0.00186	CcSEcCtD
Nabumetone—Cough—Methotrexate—muscle cancer	0.000175	0.00185	CcSEcCtD
Nabumetone—Vomiting—Etoposide—muscle cancer	0.000174	0.00183	CcSEcCtD
Nabumetone—Rash—Etoposide—muscle cancer	0.000172	0.00182	CcSEcCtD
Nabumetone—Dermatitis—Etoposide—muscle cancer	0.000172	0.00182	CcSEcCtD
Nabumetone—Headache—Etoposide—muscle cancer	0.000171	0.00181	CcSEcCtD
Nabumetone—Flatulence—Doxorubicin—muscle cancer	0.000171	0.00181	CcSEcCtD
Nabumetone—Tension—Doxorubicin—muscle cancer	0.00017	0.0018	CcSEcCtD
Nabumetone—Discomfort—Methotrexate—muscle cancer	0.000169	0.00178	CcSEcCtD
Nabumetone—Nervousness—Doxorubicin—muscle cancer	0.000169	0.00178	CcSEcCtD
Nabumetone—Confusional state—Methotrexate—muscle cancer	0.000165	0.00174	CcSEcCtD
Nabumetone—Anaphylactic shock—Methotrexate—muscle cancer	0.000164	0.00173	CcSEcCtD
Nabumetone—Nausea—Etoposide—muscle cancer	0.000162	0.00171	CcSEcCtD
Nabumetone—Ill-defined disorder—Doxorubicin—muscle cancer	0.000161	0.0017	CcSEcCtD
Nabumetone—Anaemia—Doxorubicin—muscle cancer	0.00016	0.00169	CcSEcCtD
Nabumetone—Thrombocytopenia—Methotrexate—muscle cancer	0.00016	0.00169	CcSEcCtD
Nabumetone—Agitation—Doxorubicin—muscle cancer	0.00016	0.00169	CcSEcCtD
Nabumetone—Hyperhidrosis—Methotrexate—muscle cancer	0.000158	0.00167	CcSEcCtD
Nabumetone—Malaise—Doxorubicin—muscle cancer	0.000157	0.00165	CcSEcCtD
Nabumetone—Vertigo—Doxorubicin—muscle cancer	0.000156	0.00165	CcSEcCtD
Nabumetone—Anorexia—Methotrexate—muscle cancer	0.000156	0.00165	CcSEcCtD
Nabumetone—Syncope—Doxorubicin—muscle cancer	0.000156	0.00164	CcSEcCtD
Nabumetone—Leukopenia—Doxorubicin—muscle cancer	0.000155	0.00164	CcSEcCtD
Nabumetone—Palpitations—Doxorubicin—muscle cancer	0.000153	0.00162	CcSEcCtD
Nabumetone—Loss of consciousness—Doxorubicin—muscle cancer	0.000153	0.00161	CcSEcCtD
Nabumetone—Cough—Doxorubicin—muscle cancer	0.000152	0.0016	CcSEcCtD
Nabumetone—Hypertension—Doxorubicin—muscle cancer	0.00015	0.00158	CcSEcCtD
Nabumetone—Insomnia—Methotrexate—muscle cancer	0.000148	0.00156	CcSEcCtD
Nabumetone—Anxiety—Doxorubicin—muscle cancer	0.000147	0.00156	CcSEcCtD
Nabumetone—Paraesthesia—Methotrexate—muscle cancer	0.000147	0.00155	CcSEcCtD
Nabumetone—Discomfort—Doxorubicin—muscle cancer	0.000146	0.00154	CcSEcCtD
Nabumetone—Dyspnoea—Methotrexate—muscle cancer	0.000146	0.00154	CcSEcCtD
Nabumetone—Somnolence—Methotrexate—muscle cancer	0.000145	0.00154	CcSEcCtD
Nabumetone—Dry mouth—Doxorubicin—muscle cancer	0.000145	0.00153	CcSEcCtD
Nabumetone—Dyspepsia—Methotrexate—muscle cancer	0.000144	0.00152	CcSEcCtD
Nabumetone—Confusional state—Doxorubicin—muscle cancer	0.000143	0.00151	CcSEcCtD
Nabumetone—Decreased appetite—Methotrexate—muscle cancer	0.000142	0.0015	CcSEcCtD
Nabumetone—Oedema—Doxorubicin—muscle cancer	0.000142	0.0015	CcSEcCtD
Nabumetone—Anaphylactic shock—Doxorubicin—muscle cancer	0.000142	0.0015	CcSEcCtD
Nabumetone—Fatigue—Methotrexate—muscle cancer	0.000141	0.00149	CcSEcCtD
Nabumetone—PTGS2—hindlimb—muscle cancer	0.000141	0.16	CbGeAlD
Nabumetone—Shock—Doxorubicin—muscle cancer	0.000139	0.00147	CcSEcCtD
Nabumetone—Thrombocytopenia—Doxorubicin—muscle cancer	0.000139	0.00147	CcSEcCtD
Nabumetone—Hyperhidrosis—Doxorubicin—muscle cancer	0.000137	0.00145	CcSEcCtD
Nabumetone—Anorexia—Doxorubicin—muscle cancer	0.000135	0.00143	CcSEcCtD
Nabumetone—Feeling abnormal—Methotrexate—muscle cancer	0.000135	0.00142	CcSEcCtD
Nabumetone—Gastrointestinal pain—Methotrexate—muscle cancer	0.000134	0.00141	CcSEcCtD
Nabumetone—Urticaria—Methotrexate—muscle cancer	0.00013	0.00137	CcSEcCtD
Nabumetone—Abdominal pain—Methotrexate—muscle cancer	0.000129	0.00137	CcSEcCtD
Nabumetone—Body temperature increased—Methotrexate—muscle cancer	0.000129	0.00137	CcSEcCtD
Nabumetone—Insomnia—Doxorubicin—muscle cancer	0.000128	0.00135	CcSEcCtD
Nabumetone—Paraesthesia—Doxorubicin—muscle cancer	0.000127	0.00134	CcSEcCtD
Nabumetone—Dyspnoea—Doxorubicin—muscle cancer	0.000126	0.00133	CcSEcCtD
Nabumetone—Somnolence—Doxorubicin—muscle cancer	0.000126	0.00133	CcSEcCtD
Nabumetone—Dyspepsia—Doxorubicin—muscle cancer	0.000125	0.00132	CcSEcCtD
Nabumetone—Decreased appetite—Doxorubicin—muscle cancer	0.000123	0.0013	CcSEcCtD
Nabumetone—Fatigue—Doxorubicin—muscle cancer	0.000122	0.00129	CcSEcCtD
Nabumetone—Constipation—Doxorubicin—muscle cancer	0.000121	0.00128	CcSEcCtD
Nabumetone—PTGS2—appendage—muscle cancer	0.000121	0.138	CbGeAlD
Nabumetone—Hypersensitivity—Methotrexate—muscle cancer	0.000121	0.00127	CcSEcCtD
Nabumetone—Asthenia—Methotrexate—muscle cancer	0.000117	0.00124	CcSEcCtD
Nabumetone—Feeling abnormal—Doxorubicin—muscle cancer	0.000117	0.00123	CcSEcCtD
Nabumetone—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000116	0.00122	CcSEcCtD
Nabumetone—Pruritus—Methotrexate—muscle cancer	0.000116	0.00122	CcSEcCtD
Nabumetone—Urticaria—Doxorubicin—muscle cancer	0.000113	0.00119	CcSEcCtD
Nabumetone—Abdominal pain—Doxorubicin—muscle cancer	0.000112	0.00118	CcSEcCtD
Nabumetone—Body temperature increased—Doxorubicin—muscle cancer	0.000112	0.00118	CcSEcCtD
Nabumetone—Diarrhoea—Methotrexate—muscle cancer	0.000112	0.00118	CcSEcCtD
Nabumetone—Dizziness—Methotrexate—muscle cancer	0.000108	0.00114	CcSEcCtD
Nabumetone—Hypersensitivity—Doxorubicin—muscle cancer	0.000104	0.0011	CcSEcCtD
Nabumetone—Vomiting—Methotrexate—muscle cancer	0.000104	0.0011	CcSEcCtD
Nabumetone—Rash—Methotrexate—muscle cancer	0.000103	0.00109	CcSEcCtD
Nabumetone—Dermatitis—Methotrexate—muscle cancer	0.000103	0.00109	CcSEcCtD
Nabumetone—Headache—Methotrexate—muscle cancer	0.000103	0.00108	CcSEcCtD
Nabumetone—Asthenia—Doxorubicin—muscle cancer	0.000102	0.00107	CcSEcCtD
Nabumetone—Pruritus—Doxorubicin—muscle cancer	0.0001	0.00106	CcSEcCtD
Nabumetone—Nausea—Methotrexate—muscle cancer	9.72e-05	0.00103	CcSEcCtD
Nabumetone—Diarrhoea—Doxorubicin—muscle cancer	9.7e-05	0.00102	CcSEcCtD
Nabumetone—Naproxen—PTGS2—muscle cancer	9.6e-05	1	CrCbGaD
Nabumetone—Dizziness—Doxorubicin—muscle cancer	9.37e-05	0.00099	CcSEcCtD
Nabumetone—Vomiting—Doxorubicin—muscle cancer	9.01e-05	0.000952	CcSEcCtD
Nabumetone—Rash—Doxorubicin—muscle cancer	8.94e-05	0.000944	CcSEcCtD
Nabumetone—Dermatitis—Doxorubicin—muscle cancer	8.93e-05	0.000943	CcSEcCtD
Nabumetone—Headache—Doxorubicin—muscle cancer	8.88e-05	0.000938	CcSEcCtD
Nabumetone—Nausea—Doxorubicin—muscle cancer	8.42e-05	0.000889	CcSEcCtD
Nabumetone—MPO—renal system—muscle cancer	6.7e-05	0.0763	CbGeAlD
Nabumetone—MPO—bone marrow—muscle cancer	5.07e-05	0.0577	CbGeAlD
Nabumetone—MPO—head—muscle cancer	4.48e-05	0.051	CbGeAlD
Nabumetone—MPO—testis—muscle cancer	4.33e-05	0.0493	CbGeAlD
Nabumetone—PTGS2—embryo—muscle cancer	4.02e-05	0.0457	CbGeAlD
Nabumetone—CYP1A2—renal system—muscle cancer	3.67e-05	0.0418	CbGeAlD
Nabumetone—PTGS1—smooth muscle tissue—muscle cancer	3.3e-05	0.0376	CbGeAlD
Nabumetone—PTGS1—renal system—muscle cancer	3.18e-05	0.0362	CbGeAlD
Nabumetone—PTGS2—smooth muscle tissue—muscle cancer	3.16e-05	0.0359	CbGeAlD
Nabumetone—PTGS2—renal system—muscle cancer	3.04e-05	0.0346	CbGeAlD
Nabumetone—PTGS1—cardiac atrium—muscle cancer	2.85e-05	0.0324	CbGeAlD
Nabumetone—PTGS1—tendon—muscle cancer	2.48e-05	0.0282	CbGeAlD
Nabumetone—PTGS2—tendon—muscle cancer	2.37e-05	0.027	CbGeAlD
Nabumetone—PTGS1—vagina—muscle cancer	2.3e-05	0.0262	CbGeAlD
Nabumetone—PTGS2—bone marrow—muscle cancer	2.3e-05	0.0262	CbGeAlD
Nabumetone—PTGS2—vagina—muscle cancer	2.2e-05	0.0251	CbGeAlD
Nabumetone—PTGS1—head—muscle cancer	2.13e-05	0.0242	CbGeAlD
Nabumetone—PTGS1—testis—muscle cancer	2.05e-05	0.0234	CbGeAlD
Nabumetone—PTGS2—head—muscle cancer	2.03e-05	0.0231	CbGeAlD
